Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

GSK-3β-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by β-catenin and protein phosphatase 2A complexed with Axin

Abstract

Axin forms a complex with adenomatous polyposis coli gene product (APC), glycogen synthase kinase-3β (GSK-3β), and β-catenin through different binding sites and downregulates β-catenin. GSK-3β-dependent phosphorylation of APC-(1211-2075) which has the Axin-binding site was facilitated by Axin, but that of APC-(959-1338) which lacks the Axin-binding site was not. Axin-(298-506) or Axin-(298-832), which has the GSK-3β- and β-catenin- but not APC-binding sites, did not enhance GSK-3β-dependent phosphorylation of either APC-(1211-2075) or APC-(959-1338). Furthermore, β-catenin stimulated the phosphorylation of APC-(959-1338) and APC-(1211-2075) by GSK-3β in the presence of Axin. Consistent with these in vitro observations, expression of β-catenin or Axin in COS cells promoted an SDS gel band shift of APC. These results indicate that APC complexed with Axin is effectively phosphorylated by GSK-3β and that β-catenin may modulate this phosphorylation. In addition, the heterodimeric form of protein phosphatase 2A (PP2A) directly bound to Axin, and PP2A complexed with Axin dephosphorylated APC phosphorylated by GSK-3β. Taken together, these results suggest that GSK-3β-dependent phosphorylation of APC can be modulated by β-catenin and PP2A complexed with Axin.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Aberle H, Bauer A, Stappert J, Kispert A and Kemler R. . 1997 EMBO J. 16: 3797–3804.

  • Behrens J, Jerchow B-A, Würtele M, Grimm J, Asbrand C, Wirtz R, Kühl M, Wedlich D and Birchmeier W. . 1998 Science 280: 596–599.

  • Behrens J, von Kries JP, Kühl M, Bruhn L, Wedlich D, Grosschedl R and Birchmeier W. . 1996 Nature 382: 638–642.

  • Cadigan KM and Nusse R. . 1997 Genes Dev. 11: 3286–3305.

  • Cohen P. . 1989 Annu. Rev. Biochem. 58: 453–508.

  • Cook D, Fry MJ, Hughes K, Sumathipala R, Woodgett JR and Dale TC. . 1996 EMBO J. 15: 4526–4536.

  • Dale TC. . 1998 Biochem. J. 329: 209–223.

  • Hamada F, Tomoyasu Y, Takatsu Y, Nakamura M, Nagai S-I, Suzuki A, Fujita F, Shibuya H, Toyoshima K, Ueno N and Akiyama T. . 1999 Science 283: 1739–1742.

  • Hart MJ, de los Santos R, Albert IN, Rubinfeld B and Polakis P. . 1998 Curr. Biol. 8: 573–581.

  • He T, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW. . 1998 Science 281: 1509–1512.

  • Hériché JK, Lebrin F, Rabilloud T, Leroy D, Chambaz EM and Goldberg Y. . 1997 Science 276: 952–955.

  • Hinoi T, Kishida S, Koyama S, Ikeda M, Matsuura Y and Kikuchi A. . 1996 J. Biol. Chem. 271: 19710–19716.

  • Hsu W, Zeng L and Costantini F. . 1999 J. Biol. Chem. 274: 3439–3445.

  • Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S and Kikuchi A. . 1998 EMBO J. 17: 1371–1384.

  • Itoh K, Krupnik VE and Sokol SY. . 1998 Curr. Biol. 8: 591–594.

  • Kikuchi A and Williams LT. . 1996 J. Biol. Chem. 271: 588–594.

  • Kishida M, Koyama S, Kishida S, Matsubara K, Nakashima S, Higano K, Takada R, Takada S and Kikuchi A. . 1999a Oncogene 18: 979–985.

  • Kishida S, Yamamoto H, Hino S, Ikeda S, Kishida M and Kikuchi A. . 1999b Mol. Cell. Biol. 19: 4414–4422.

  • Kishida S, Yamamoto H, Ikeda S, Kishida M, Sakamoto I, Koyama S and Kikuchi A. . 1998 J. Biol. Chem. 273: 10823–10826.

  • Kitagawa M, Hatakeyama S, Shirane M, Matsumoto M, Ishida N, Hattori K, Nakamichi I, Kikuchi A, Nakayama K and Nakayama K. . 1999 EMBO J. 18: 2401–2410.

  • Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, Ilyas M, Bodmer WF, Moyer MP, Riecken EO, Buhr HJ and Hanski C. . 1999 Proc. Natl. Acad. Sci. USA 96: 1603–1608.

  • Matsumine A, Ogai A, Senda T, Okumura N, Satoh K, Baeg GH, Kawahara T, Kobayashi S, Okada M, Toyoshima K and Akiyama T. . 1996 Science 272: 1020–1023.

  • Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, Korinek V, Roose J, Destrée O and Clevers H. . 1996 Cell 86: 391–399.

  • Munemitsu S, Albert I, Rubinfeld B and Polakis P. . 1996 Mol. Cell. Biol. 16: 4088–4094.

  • Munemitsu S, Albert I, Souza B, Rubinfeld B and Polakis P. . 1995 Proc. Natl. Acad. Sci. USA 92: 3046–3050.

  • Murai H, Okazaki M and Kikuchi A. . 1996 FEBS Lett. 392: 153–160.

  • Polakis P. . 1997 Biochim. Biophys. Acta 1332: F127–F147.

  • Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S and Polakis P. . 1996 Science 272: 1023–1026.

  • Rubinfeld B, Albert I, Porfiri E, Munemitsu S and Polakis P. . 1997 Cancer Res. 57: 4624–4630.

  • Rubinfeld B, Souza B, Albert I, Munemitsu S and Polakis P. . 1995 J. Biol. Chem. 270: 5549–5555.

  • Rubinfeld B, Souza B, Albert I, Müller O, Chamberlain SH, Masiarz FR, Munemitsu S and Polakis P. . 1993 Science 262: 1731–1734.

  • Sakanaka C, Weiss JB and Williams LT. . 1998 Proc. Natl. Acad. Sci. USA 95: 3020–3023.

  • Seeling JM, Miller JR, Gil R, Moon RT, White R and Virship DM. . 1999 Science 283: 2089–2091.

  • Su LK, Vogelstein B and Kinzler KW. . 1993 Science 262: 1734–1737.

  • Takeichi M. . 1991 Science 251: 1451–1455.

  • Tetsu O and McCormick F. . 1999 Nature 398: 422–426.

  • Usui H, Imazu M, Maeta K, Tsukamoto H, Azuma K and Takeda M. . 1988 J. Biol. Chem. 263: 3752–3761.

  • Westphal RS, Anderson KA, Means AR and Wadzinski BE. . 1998 Science 280: 1258–1261

  • Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ and Harper JW. . 1999 Genes Dev. 13: 270–283.

  • Yamamoto H, Kishida S, Kishida M, Ikeda S, Takada S and Kikuchi A. . 1999 J. Biol. Chem. 274: 10681–10684.

  • Yamamoto H, Kishida S, Uochi T, Ikeda S, Koyama S, Asashima M and Kikuchi A. . 1998 Mol. Cell. Biol. 18: 2867–2875.

  • Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry III WL, Lee JJ, Tilghman SM, Gumbiner BM and Costantini F. . 1997 Cell 90: 181–192.

  • Zolnierowicz S, van Hoof C, Andjelkovic N, Cron P, Stevens I, Merlevede W, Goris J and Hemmings BA. . 1996 Biochem. J. 317: 187–194.

Download references

Acknowledgements

We thank Dr M Takeda for helpful discussion and critical reading of the manuscript. We are grateful to Drs JR Woodgett, T Akiyama, A Nagafuchi, CW Turck, M Nakata, and K Yonezawa for providing plasmids, peptides, and antibodies. This work was supported by grants-in-aid for scientific research and for scientific research on priority areas from the Ministry of Education, Science, and Culture, Japan (1998, 1999), and by grants from the Yamanouchi Foundation for Research on Metabolic Disorders (1998), and Uehara Memorial Foundation (1998). We wish to thank the Research Center for Molecular Medicine, Hiroshima University School of Medicine, for the use of their facilities.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ikeda, S., Kishida, M., Matsuura, Y. et al. GSK-3β-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by β-catenin and protein phosphatase 2A complexed with Axin. Oncogene 19, 537–545 (2000). https://doi.org/10.1038/sj.onc.1203359

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203359

Keywords

This article is cited by

Search

Quick links